NCT05922397 Placenta Accreta Spectrum Topographic Classification
| NCT ID | NCT05922397 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundacion Clinica Valle del Lili |
| Condition | Placenta Accreta |
| Study Type | OBSERVATIONAL |
| Enrollment | 326 participants |
| Start Date | 2023-05-21 |
| Primary Completion | 2025-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 326 participants in total. It began in 2023-05-21 with a primary completion date of 2025-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The present study is a prospective multicenter study consisting of a cohort of patients with prenatal or intraoperative diagnosis of PAS, evaluating the clinical outcomes of the group of patients found in each category of the topographic classification. In addition, an approach to evaluate the acceptability of this classification among the obstetrician-gynecologists of the participating medical centers will be included.
Eligibility Criteria
Inclusion Criteria: * Pregnant woman over 18 years old. * Prenatal diagnosis by ultrasound or MRI of Placenta Accreta Spectrum (PAS), regardless of the suspected degree of severity of the disease. * Case requiring surgical management, either as scheduled or emergent procedure. * Application of the topographic classification of placenta accreta spectrum during laparotomy. Exclusion Criteria: * None.
Contact & Investigator
Albaro J Nieto-Calvache, MD
PRINCIPAL INVESTIGATOR
Fundacion Clinica Valle del Lili
Frequently Asked Questions
Who can join the NCT05922397 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 55 Years, studying Placenta Accreta. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05922397 currently recruiting?
Yes, NCT05922397 is actively recruiting participants. Contact the research team at albaro.nieto@fvl.org.co for enrollment information.
Where is the NCT05922397 trial being conducted?
This trial is being conducted at Cali, Colombia.
Who is sponsoring the NCT05922397 clinical trial?
NCT05922397 is sponsored by Fundacion Clinica Valle del Lili. The principal investigator is Albaro J Nieto-Calvache, MD at Fundacion Clinica Valle del Lili. The trial plans to enroll 326 participants.